(ADAP) Adaptimmune Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Adaptimmune Therapeutics | (ADAP) share price targets
Complete technical analysis of Adaptimmune Therapeutics (ADAP) by charts plus indicators, forecast predictions and share price targets for Adaptimmune Therapeutics (ADAP)
Adaptimmune Therapeutics trades in USA in Health Care sector.
10 day averaged volume of Adaptimmune Therapeutics is 1590300
| Date | Daily Closing Price | Open | High | Low | Volume |
| 24 Wed Apr 2024 | 1.08 | 1.14 | 1.15 | 1.07 | 0.495 times |
| 23 Tue Apr 2024 | 1.14 | 1.04 | 1.16 | 1.00 | 0.713 times |
| 22 Mon Apr 2024 | 1.01 | 0.99 | 1.08 | 0.94 | 0.437 times |
| 19 Fri Apr 2024 | 0.98 | 0.92 | 1.10 | 0.92 | 0.932 times |
| 18 Thu Apr 2024 | 0.90 | 0.97 | 0.99 | 0.87 | 2.104 times |
| 17 Wed Apr 2024 | 0.99 | 1.02 | 1.05 | 0.93 | 0.769 times |
| 16 Tue Apr 2024 | 1.03 | 1.05 | 1.06 | 0.98 | 0.77 times |
| 15 Mon Apr 2024 | 1.05 | 1.20 | 1.21 | 1.05 | 0.833 times |
| 12 Fri Apr 2024 | 1.16 | 1.20 | 1.28 | 1.13 | 1.936 times |
| 11 Thu Apr 2024 | 1.29 | 1.28 | 1.34 | 1.26 | 0.555 times |
My analysis of stock is bearish for shortterm, but stock is semi over sold and there are some chances of seeing a recovery tomorrow. Use 1 as stoploss in an intra day buy trade for a target of 1.24. However, stock will show a bearish move below 1.
Share price targets for Adaptimmune Therapeutics (ADAP)
| Target Type | Value |
| Downside Target | 0.43 |
| Downside Target | 0.65 |
| Downside Target | 0.84 |
| Downside Target | 0.87 |
| Downside Target | 0.92 |
| Downside Target | 0.94 |
| Downside Target | 1.04 |
| Upside Target | 1.13 |
| Upside Target | 1.16 |
| Upside Target | 1.21 |
| Upside Target | 1.24 |
| Upside Target | 1.32 |
| Upside Target | 1.38 |
| Upside Target | 1.41 |
| Upside Target | 1.55 |
| Upside Target | 1.65 |
| Upside Target | 1.79 |
| Upside Target | 2.05 |
Intraday share price targets for Adaptimmune Therapeutics (ADAP)
| Target Type | Value |
| Downside Intraday Target | 0.96 |
| Downside Intraday Target | 0.84 |
| Upside Intraday Target | 1.18 |
| Upside Intraday Target | 1.28 |
| Downside Intraday Target | 1.06 |
Weekly technical analysis of Adaptimmune Therapeutics (ADAP)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 24 Wed Apr 2024 | 1.08 | 0.99 | 1.16 | 0.94 | 0.304 times |
| 19 Fri Apr 2024 | 0.98 | 1.20 | 1.21 | 0.87 | 1.191 times |
| 12 Fri Apr 2024 | 1.16 | 1.40 | 1.41 | 1.13 | 1.183 times |
| 05 Fri Apr 2024 | 1.37 | 1.55 | 1.55 | 1.32 | 1.32 times |
| 28 Thu Mar 2024 | 1.58 | 1.46 | 1.65 | 1.38 | 0.566 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Adaptimmune Therapeutics (ADAP)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 24 Wed Apr 2024 | 1.08 | 1.55 | 1.55 | 0.87 | 0.621 times |
| 28 Thu Mar 2024 | 1.58 | 1.56 | 2.05 | 1.24 | 1.055 times |
| 29 Thu Feb 2024 | 1.57 | 1.03 | 1.79 | 0.92 | 0.965 times |
| 31 Wed Jan 2024 | 0.96 | 0.81 | 1.04 | 0.65 | 2.174 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Adaptimmune Therapeutics (ADAP)
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Adaptimmune Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Adaptimmune Therapeutics in short term and the sell signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Adaptimmune Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Adaptimmune Therapeutics in short term
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Adaptimmune Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.05 and Adaptimmune Therapeutics (ADAP) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Adaptimmune Therapeutics (ADAP) stock. Volume based technical analysis of Adaptimmune Therapeutics (ADAP) stock is negative.
Adaptimmune Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Adaptimmune Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Adaptimmune Therapeutics in short term and the sell signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Adaptimmune Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Adaptimmune Therapeutics in short term
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Adaptimmune Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.05 and Adaptimmune Therapeutics (ADAP) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Adaptimmune Therapeutics (ADAP) stock. Volume based technical analysis of Adaptimmune Therapeutics (ADAP) stock is negative.
Adaptimmune Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.